Hallucinogens are a class of drugs that can cause changes in perception, mood, and thought. They have been used for centuries by various cultures around the world for spiritual or recreational purposes. In recent years, there has been an increase in research into hallucinogen use and its effects on individuals and society as a whole. This blog post will explore some statistics related to hallucinogen use from different countries across the globe including the United States, Europe, Oceania, Canada, New Zealand Scotland Ireland France and America Association of Poison Control Centers (AAPCC).
We'll look at lifetime prevalence rates among adults aged 15-64; initiation rates among those 12 or older; trends over time among 8th-, 10th-, and 12th-graders; treatment utilization rate; first-time user increases between 2017 & 2020 Global Drug Surveys; exposed cases reported to AAPCC in 2019 etc., providing insight into how this drug is being used today.
Hallucinogen Statistics Overview
Between 2015 and 2019, hallucinogen use among 8th, 10th, and 12th graders in the United States decreased from 3.3% to 2.9%.
This statistic is a testament to the success of efforts to reduce hallucinogen use among 8th, 10th, and 12th graders in the United States. It shows that the hard work of educators, parents, and other stakeholders is paying off, and that the trend of decreasing hallucinogen use is continuing. This is an encouraging sign that the dangers of hallucinogen use are being taken seriously and that the necessary steps are being taken to protect young people from the risks associated with these substances.
The lifetime prevalence of hallucinogen use in 2016 was 14.6% in the United States, 6.5% in Europe, and 8.6% in Oceania among people ages 15 to 64.
This statistic is a powerful indicator of the prevalence of hallucinogen use across the globe. It reveals that the United States has the highest rate of hallucinogen use, followed by Europe and Oceania. This information is essential for understanding the scope of hallucinogen use and its potential impact on public health. It also provides a valuable insight into the differences in hallucinogen use between different regions, which can help inform policy decisions and public health initiatives.
About 93.7% of those who had hallucinogen use disorder in the United States did not receive treatment (2018).
This statistic is a stark reminder of the lack of access to treatment for those suffering from hallucinogen use disorder in the United States. It highlights the need for more resources to be made available to those who need help, as well as the need for greater awareness of the issue.
The 2017 Global Drug Survey found that 28.6% of participants reported using psychedelics (a subclass of hallucinogens) at least once in their lives.
This statistic is a powerful indicator of the prevalence of psychedelics in our society. It shows that a significant portion of the population has experimented with these substances, which can be used to inform public policy and health initiatives. Additionally, it can be used to help inform people about the potential risks and benefits of psychedelics, and to help them make informed decisions about their own use.
The 2020 Global Drug Survey found a 49% increase in the use of 2C-B (a hallucinogen) among first-time users compared to the previous year.
This statistic is a telling indication of the growing popularity of 2C-B as a hallucinogen among first-time users. It highlights the need for further research into the effects of this drug and the potential risks associated with its use. It also serves as a reminder of the importance of educating people about the potential dangers of using hallucinogens.
820,000 people aged 12 or older initiated hallucinogen use in 2019 in the United States.
This statistic is a stark reminder of the prevalence of hallucinogen use in the United States. It highlights the fact that hallucinogens are still being used by a large number of people, and that this is an issue that needs to be addressed. It also serves as a reminder that hallucinogen use is not a problem that is going away anytime soon, and that it is important to be aware of the risks associated with these substances.
Between 2000 and 2019, there were 589 reports on 5-MeO-DMT (a hallucinogen) to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
This statistic is a telling indication of the prevalence of 5-MeO-DMT, a hallucinogen, in Europe over the past two decades. It demonstrates that the drug has been a subject of interest to the EMCDDA, and that its use has been significant enough to warrant 589 reports. This is an important piece of information for anyone looking to gain an understanding of the hallucinogen landscape in Europe.
In 2020, 2.2% of high school seniors in the United States reported using LSD (a hallucinogen) in the past year.
This statistic is a telling indication of the prevalence of LSD use among high school seniors in the United States. It provides a snapshot of the current state of hallucinogen use among this age group, and can be used to inform discussions about the potential risks and benefits of using these substances.
In 2019, 3.3% of young people in New Zealand reported using hallucinogens in the past year.
This statistic is a telling indication of the prevalence of hallucinogen use among young people in New Zealand. It provides a snapshot of the current state of hallucinogen use in the country, and can be used to inform policy decisions and public health initiatives. It also serves as a reminder that hallucinogen use is a reality for many young people, and that it is important to be aware of the potential risks associated with it.
In 2019, 4.3% of people aged 16 to 59 in Scotland had used hallucinogens in their lifetime.
This statistic is a valuable insight into the prevalence of hallucinogen use in Scotland. It provides a snapshot of the number of people who have used hallucinogens in their lifetime, and can be used to compare the usage of hallucinogens in Scotland to other countries or regions. Additionally, this statistic can be used to inform public health initiatives and policies related to hallucinogen use in Scotland.
The prevalence of lifetime hallucinogen use among French adults aged 18-64 increased from 2.9% in 2005 to 4.3% in 2017.
This statistic is a telling indication of the growing popularity of hallucinogen use among French adults. It demonstrates that the use of hallucinogens is becoming increasingly commonplace, and that more and more people are experimenting with these substances. This is an important statistic to consider when discussing hallucinogen statistics, as it provides insight into the changing attitudes and behaviors of the French population.
In 2019, 2.2% of Irish adults aged 15 to 64 had used hallucinogens in their lifetime.
This statistic is a valuable insight into the prevalence of hallucinogen use in Ireland. It provides a snapshot of the number of people who have used hallucinogens in their lifetime, and can be used to inform public health initiatives and policies. It can also be used to compare the prevalence of hallucinogen use in Ireland to other countries, and to track changes in hallucinogen use over time.
392 exposed cases to hallucinogens were reported to the American Association of Poison Control Centers in 2019.
This statistic is a powerful indicator of the prevalence of hallucinogen use in the United States. It shows that there were 392 reported cases of people exposed to hallucinogens in 2019, which is a significant number. This statistic is important to consider when discussing the potential risks associated with hallucinogen use, as well as the potential benefits. It also provides insight into the current trends in hallucinogen use and can help inform public health policies and interventions.
Conclusion
The statistics presented in this blog post demonstrate that hallucinogen use is a global phenomenon, with prevalence rates varying across countries and regions. In the United States, 11.8% of people aged 12 or older have used hallucinogens at least once in their lifetime (2019), while 820,000 initiated use in 2019 alone. Hallucinogen use disorder affected 118,000 people aged 12 or older in the same year (2019). Between 2015 and 2019 there was a decrease from 3.3% to 2.9% among 8th, 10th and 12th graders using these drugs; however other age groups such as young adults are still reporting high levels of usage - 7.6% for those 18-24 years old living in Australia (2019) and 4.3 % for 16-59 year olds living Scotland (2019).
The Global Drug Survey found an increase of 49%, between 2018/19 compared to 2020 regarding first time users taking 2C-B – one type of hallucinogenic drug - indicating that more research needs to be done on its effects before it becomes widely available again on the market place. Furthermore 93.7 percent did not receive treatment despite having been diagnosed with hallucinations disorders(2018). This data shows us how important it is to continue researching into this area so we can better understand why some individuals choose take partaking these substances recreationally whilst others develop addictions which require medical attention.
References
0. - https://www.www.samhsa.gov
1. - https://www.www.thelancet.com
2. - https://www.www.emcdda.europa.eu
3. - https://www.www.monitoringthefuture.org
4. - https://www.www.globaldrugsurvey.com
5. - https://www.www.gov.scot
6. - https://www.piper.filecamp.com
7. - https://www.www.fmhs.auckland.ac.nz
8. - https://www.en.ofdt.fr
9. - https://www.www.drugabuse.gov
